Format

Send to

Choose Destination
Bioorg Med Chem Lett. 2008 Jan 15;18(2):554-9. Epub 2007 Nov 28.

Novel indole-3-sulfonamides as potent HIV non-nucleoside reverse transcriptase inhibitors (NNRTIs).

Author information

1
Department of Medicinal Chemistry, Merck & Co., Inc., PO Box 4, West Point, PA 19486, USA. zhijian_zhao@merck.com

Erratum in

  • Bioorg Med Chem Lett. 2010 Sep 1;20(17):5360. Sanderson, Philip E J [added].

Abstract

This Letter describes the design, synthesis, and biological evaluation of novel 3-indole sulfonamides as potent non-nucleoside reverse transcriptase inhibitors (NNRTIs) with balanced profiles against common HIV RT mutants K103N and Y181C.

PMID:
18083561
DOI:
10.1016/j.bmcl.2007.11.085
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center